HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deepti H Radia Selected Research

avapritinib

6/2023Avapritinib versus Placebo in Indolent Systemic Mastocytosis.
11/2022Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis.
1/2022Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis.
12/2021Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial.
12/2021Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Deepti H Radia Research Topics

Disease

7Systemic Mastocytosis
03/2024 - 01/2017
4Neoplasms (Cancer)
11/2021 - 12/2014
3Mastocytosis
03/2024 - 01/2022
3Mast Cell Activation Disorders (Mast-Cell Disease)
03/2024 - 01/2022
3Primary Myelofibrosis (Myelosclerosis)
06/2016 - 01/2013
2Hereditary alpha-tryptasemia syndrome
10/2023 - 11/2021
2Polycythemia Vera
06/2016 - 03/2016
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Hypersensitivity (Allergy)
01/2022
1Venous Thromboembolism
01/2020
1Cytopenia
06/2016
1Essential Thrombocythemia
06/2016
1Blast Crisis (Blast Phase)
12/2014
1Anemia
01/2013
1Splenomegaly
01/2013

Drug/Important Bio-Agent (IBA)

5avapritinibIBA
06/2023 - 12/2021
3Tryptases (Tryptase)IBA
10/2023 - 11/2021
2Janus Kinase InhibitorsIBA
01/2017 - 01/2013
2ruxolitinibIBA
03/2016 - 12/2014
2Hydroxyurea (Hydrea)FDA LinkGeneric
03/2016 - 01/2013
1Immunoglobulin E (IgE)IBA
01/2022
1AnticoagulantsIBA
01/2020
1SteroidsIBA
06/2016
1Syntex adjuvant formulationIBA
06/2016
1Immunologic Factors (Immunomodulators)IBA
06/2016
1InterferonsIBA
03/2016
1Cytarabine (Cytosar-U)FDA LinkGeneric
12/2014
1Azacitidine (5 Azacytidine)FDA Link
12/2014
1Immunomodulating AgentsIBA
01/2013
1HematinicsIBA
01/2013
1AndrogensIBA
01/2013

Therapy/Procedure

4Therapeutics
01/2022 - 12/2014
1Cell Transplantation
03/2024
1Transplantation
03/2024
1Splenectomy
01/2013